CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Agreement ended
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Business Officer bought 16,666 shares at $1.50 ($24,999)
- 4 Open-market buy Chief Executive Officer bought 66,666 shares at $1.50 ($99,999)
- 4 Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure · Other events
- 424B4 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
Page 3 of 46 · 907 filings